SAPPHIRE: phase III study of sitravatinib plus nivolumab versus docetaxel in advanced nonsquamous non-small-cell lung cancer

Autor: Abdel-Karim, Isam, Abdelsalam, Mahmoud, Addeo, Alfredo, Aguado, Carlos, Alexander, Patrick, Alt, Jürgen, Azzi, Georges, Balaraman, Rama, Biesma, Bonne, Blackhall, Fiona, Bohnet, Sabine, Boleti, Ekaterini, Borghaei, Hossein, Bradbury, Penelope, Brighenti, Matteo, Campbell, Nicholas, Campbell, Toby, Canon, Jean-Luc, Cappuzzo, Federico, Costa, Enric Carcereny, Cavanna, Luigi, Cetnar, Jeremy, Chella, Antonio, Chouaid, Christos, Christoph, Daniel, Castán, Javier Cortés, Dakhil, Shaker, de Castro Carpeño, Francisco Javier, de Marinis, Filippo, Delmonte, Angelo, Demedts, Ingel, Demey, Wim, Dits, Joyce, del Pilar Diz Taín, Maria, Gómez, Manuel Dómine, Dorius, Timothy, Dumoulin, Daphne, Duruisseaux, Michaël, Eaton, Keith, González, Emilio Esteban, Evans, Devon, Faehling, Martin, Farrell, Nicholas, Feinstein, Trevor, Font, Enriqueta Felip, Garcia Campelo, Maria Rosario, Garon, Edward, Garrido López, María Pilar, Germonpré, Paul, Gersten, Todd, Cao, Maria Gonzalez, Gopaluni, Srivalli, Greillier, Laurent, Grossi, Francesco, Guisier, Florian, Gurubhagavatula, Sarada, Calderón, Vanesa Gutiérrez, Hakimian, David, Hall, Richard, Jr., Hao, Desirée, Harris, Ronald, Hashemi, Sayed, He, Kai, Hendriks, Lizza, Huang, Chao, Ibrahim, Emad, Jain, Sharad, Johnson, Melissa, Jones, Benjamin, Jones, Monte, Juan Vidal, Óscar José, Juergens, Rosalyn, Kaderbhai, Courèche, Kastelijn, Elisabeth A (Lisanne), Keresztes, Roger, Kio, Ebenezer, Kokowski, Konrad, Konduri, Kartik, Kulkarni, Swati, Kuon, Jonas, Kurkjian, Carla, Labbé, Catherine, Lerner, Rachel, Lim, Farah, Madroszyk-Flandin, Anne, Marathe, Omkar, Martincic, Danko, McClay, Edward, McIntyre, Kristi, Mekhail, Tarek, Misino, Andrea, Molinier, Olivier, Morabito, Alessandro, Morócz, Éva, Müller, Veronika, Nagy, Tünde, Nguyen, Anthony V., Nidhiry, Emmanuel, Okazaki, Ian, Ortega-Granados, Ana Laura, Ostoros, Gyula, Oubre, David, Owen, Scott, Pachipala, Krishna, Park, David, Patel, Pareshkumar, Percent, Ivor, Pérol, Maurice, Peters, Solange, Piet, Berber, Planchard, David, Polychronis, Andreas, Aix, Santiago Ponce, Pons-Tostivint, Elvire, Popat, Sanjaykumar, Pulla, Mariano Provencio, Quantin, Xavier, Quéré, Gilles, Rafique, Noman, Ramaekers, Ryan, Reck, Martin, Reiman, Anthony, Reinmuth, Niels, Reynolds, Craig, Rodríguez-Abreu, Delvys, Romano, Gianpiero, Roque, Tammy, Salzberg, Matthew, Sanborn, Rachel, Sandiego, Sergio, Schaefer, Eric, Schreeder, Marshall, Seetharamu, Nagashree, Seneviratne, Lasika, Shah, Purvi, Shunyakov, Leonid, Slater, Dennis, Parra, Hector Soto, Stigt, Johannes, Stilwill, Joseph, Su, Jingdong, Surmont, Veerle, Swink, Alicia, Szalai, Zsuzsanna, Talbot, Toby, Garcia, Alvaro Taus, Theelen, Willemijn, Thompson, Jonathan, Tiseo, Marcello, Uprety, Dipesh, Uyeki, James, van der Leest, Kornelius Cor, Van Ho, Anthony, van Putten, John, Estévez, Sergio Vázquez, Veatch, Andrea, Vergnenègre, Alain, Ward, Patrick, Weise, Amy, Weiss, Matthias, Whitehurst, Matthew, Zai, Silvia, Zalcman, Gérard, Zuniga, Richard, Borghaei, H., de Marinis, F., Dumoulin, D., Reynolds, C., Theelen, W.S.M.E., Percent, I., Gutierrez Calderon, V., Johnson, M.L., Madroszyk-Flandin, A., Garon, E.B., He, K., Planchard, D., Reck, M., Popat, S., Herbst, R.S., Leal, T.A., Shazer, R.L., Yan, X., Harrigan, R., Peters, S.

Publikováno v: In Annals of Oncology January 2024 35(1):66-76

871P Randomized phase II trial of nivolumab plus paclitaxel in subjects with recurrent/metastatic head and neck squamous cell carcinoma (R/M HNSCC) unable for cisplatin (CP)-based chemotherapy (CT): NIVOTAX TTCC study

Autor: Iglesias Docampo, L., Baste Rotllan, N., Oliva Bernal, M., Carral Maseda, A., Pérez Segura, P., Medina Colmenero, A., Cirauqui Cirauqui, B., Arrazubi Arrula, V., Martinez Trufero, J., Gutierrez Calderon, V., Garcia Castano, A., Rubió-Casadevall, J., Basterretxea, L., Alvarez Cabellos, R., del Barco Morillo, E., Bruixola, G., Flor, M.J., Assaf Pastrana, J.D., Caballero Daroqui, J., Mesia Nin, R.

Publikováno v: In Annals of Oncology September 2024 35 Supplement 2:S624-S624

1481P Singular immune-related adverse events and efficacy outcomes of immune checkpoint inhibitors in advanced non-small cell lung cancer

Autor: Jurado García, J.M., Cobo Dols, M., Cantero, A., Gutierrez Calderon, V., Jiménez Gallego, P., Perez Ruiz, E., Berciano Guerrero, M.A., Montesa Pino, A., Ramos Garcia, I., Rueda Dominguez, A.

Publikováno v: In Annals of Oncology October 2023 34 Supplement 2:S837-S838

1532P Phase IIIb study of durvalumab plus platinum-etoposide in first-line treatment of extensive-stage small cell lung cancer (CANTABRICO): Preliminary efficacy results

Autor: Isla, D., Arriola, E., Garcia Campelo, M.R., Diz Tain, P., Marti Blanco, C., Lopez-Brea Piqueras, M.M., Moreno Vega, A.L., Leon Mateos, L.A., Oramas Rodriguez, J.M., Gutierrez Calderon, V., Majem Tarruella, M., Sanchez Hernandez, A., Aguado de la Rosa, C., Alvarez Cabellos, R., Marti Ciriquian, J.L., Moreno Paul, A., Firvida Perez, J.L., Callejo Mellén, Á., Baez, L., Paz-Ares, L.

Publikováno v: In Annals of Oncology September 2022 33 Supplement 7:S1247-S1248

1667TiP Durvalumab plus platinum-etoposide in first-line treatment of extensive-stage small cell lung cancer (CANTABRICO): A Spanish phase IIIb single arm, real-world study

Autor: Paz-Ares, L., Arriola, E., Campelo, M.R. Garcia, Tain, M.P. Diz, Blanco, M.C. Marti, Vega, A.L. Moreno, Leon-Mateos, L., Gutierrez Calderon, V., Sanchez Hernandez, A., Rodriguez, J.M. Oramas, Majem, M., Aguado de la Rosa, C., Alvarez Cabellos, R., Ciriquian, J.L. Marti, Amezcua, V., Perez, J.L. Firvida, Mellén, Á. Callejo, Baez, L., Isla, D.

Publikováno v: In Annals of Oncology September 2021 32 Supplement 5:S1171-S1172